Today: 17 May 2026
Bitmine Immersion Technologies Stock Jumps After New Filing Shows $11.5 Billion in Crypto and Cash
16 March 2026
1 min read

Bitmine Immersion Technologies Stock Jumps After New Filing Shows $11.5 Billion in Crypto and Cash

NEW YORK, March 16, 2026, 11:38 EDT

Bitmine Immersion Technologies shares climbed 11.6% late Monday morning, after an 8-K filing showed its crypto, cash, and investment holdings totaled $11.5 billion. The stock recently changed hands at $22.93, not far from the session peak of $23.21.

This shift is significant: Bitmine now stands out as one of the most direct listed plays on ether, the Ethereum blockchain’s native currency. Ether itself rallied roughly 9.3% to $2,288.91, a level not seen in five weeks. SharpLink picked up 8.2%, with BTCS following—shares up 6.3%.

Bitmine reported holding 4,595,562 ETH, 196 bitcoin, $1.2 billion in cash, a $200 million position in Beast Industries, and $83 million invested in Eightco as of 7 p.m. ET on March 15. That stash of ether amounts to 3.81% of the total supply, according to the company.

Chairman Tom Lee described crypto’s latest rally as “meaningful outperformance.” Bitmine scooped up 60,999 ETH in the last week—quicker than its usual weekly haul, he noted. Lee said management sees ether nearing the end of a “mini-crypto winter.” PR Newswire

Bitmine reported it has 3,040,515 ether staked—funds committed to validate transactions and collect rewards. According to Lee, annualized staking revenue stands at $180 million. If the rest of Bitmine’s holdings are put to work via its MAVAN validator network, rewards could climb to $272 million.

Bitmine disclosed it injected $80 million into Eightco following Eightco’s $50 million purchase of OpenAI shares and a $25 million investment in Beast Industries. The company also acquired 5,000 ETH from the Ethereum Foundation. According to Lee, this move let the foundation support its operations without needing to unload assets on the open market.

Bitmine, a bitcoin miner based in the U.S. that’s been channeling surplus funds into ether, says it still holds the largest ether treasury and ranks second among all crypto treasuries, just after Strategy. On March 9, Strategy reported holding 738,731 bitcoin. SharpLink, on that same date, disclosed it had built up 868,699 ETH.

Still, the setup remains shaky. In its Sunday evening filing, Bitmine pegged ether at $2,185, but flagged that upcoming results hinge on financing, rivals and whatever happens with bitcoin and ether prices—meaning the balance sheet could take a hit if tokens lurch again.

Stock Market Today

  • S&P/TSX Composite Drops Over 400 Points Amid Inflation Fears and Rising Oil Prices
    May 17, 2026, 3:11 AM EDT. The S&P/TSX composite index fell 434.92 points to 33,833.35, weighed down by weaker precious metals and the materials sector. U.S. markets also declined with the Dow down 537.29 points, S&P 500 off 92.74 points, and Nasdaq down 410.08 points, led lower by tech and AI stocks. Rising global oil prices, driven by the Strait of Hormuz shutdown, plus fears of higher inflation, pushed bond yields up, with the 30-year U.S. Treasury yield returning to 2007 levels. Higher yields raise borrowing costs and pressure equities. The Bank of Canada is watching April inflation data closely amid energy price impacts. The Canadian dollar dipped to 72.72 US cents. Gold prices declined amid the market turbulence.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Dow Jones, S&P 500, Nasdaq Rise on Monday as Oil Falls Ahead of Fed, but Wall Street’s Rebound Looks Fragile
Previous Story

Dow Jones, S&P 500, Nasdaq Rise on Monday as Oil Falls Ahead of Fed, but Wall Street’s Rebound Looks Fragile

Plug Power Stock Price Today: Shares Jump as New CEO Takes Turnaround Pitch to Investors
Next Story

Plug Power Stock Price Today: Shares Jump as New CEO Takes Turnaround Pitch to Investors

Go toTop